Korean Stock
MATR
KOREA PHARMA
★
Decision to Issue KRW 15 Billion Unsecured Private Convertible Bonds - Conversion Price KRW 10,782 (2.8% Premium to Current Price), Potential Dilution 11.31%
 15h ago
OWNR
KOREA PHARMA
★
Large Shareholding Report Template – No Substantive Information
 05/15/2026, 05:16 PM
PERI
KOREA PHARMA
★★
Q1 2026 Operating Profit Turns Positive, Dividend of 50 Won Per Share Maintained
 05/15/2026, 05:00 PM